Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study” - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: "Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Patients with Type 2 Diabetes - Insights from a Real-World Analysis

  • August 26, 2025

Share

Objective:

To correct errors in authorship and funding sections of the original article.

Key Findings:
  • Benaya Rozen-Zvi's name was corrected from 'Benaya Rozen Zvi' to 'Benaya Rozen-Zvi'.
  • Anat Gafter-Gvili's name was corrected from 'Anat Gafter Gvili' to 'Anat Gafter-Gvili'.
Interpretation:

The corrections ensure proper attribution and acknowledgment of the authors involved in the study.

Limitations:
  • The erratum does not address any scientific findings or data from the original study.
Conclusion:

The article has been corrected online to reflect accurate authorship and funding details.

Original Source(s)

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025

Related Content

Mild metabolic profile may mask MASLD risk

Five reproducible MASLD subtypes showed distinct genetic profiles and patterns of metabolic comorbidity and disease progression.

Ovulation may shift preferences toward conspicuous luxury

Across 3 studies, higher fertility was associated with greater preference for luxury when it was visible, personally relevant, and potentially noticeable to others.

Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk